Califf Confident Public Trust In US FDA Will Be Rebuilt

Commissioner nominee strikes an optimistic note as former FDA heads raise concerns about the decrease in agency credibility during the pandemic.

Commissioner Roundtable at CERSI innovation in reg science summit
Acting FDA Commissioner Janet Woodcock and former commissioners Robert Califf, Scott Gottlieb, Margaret Hamburg and Mark McClellan spoke with Takeda R&D President Andy Plump about the future of the FDA during a recent conference. • Source: Screenshot

More from US FDA

More from Agency Leadership